Affymetrix repurchases $95.8 million of 3.5% convertibles at discount

By Jennifer Chiou

New York, July 21 - Affymetrix Inc. announced that it has bought back $95.8 million total of its 3.5% convertibles due 2013 for $88.9 million since the beginning of the second quarter.

Specifically, the company purchased $26.7 million of the notes during the second quarter for $24.6 million. Since June 30, it has repurchased an additional $69.1 million of the convertibles at a cost of $64.3 million.

As of July 15, $151 million of the notes remains outstanding.

The Santa Clara, Calif.-based company is focused on technology used by pharmaceutical, diagnostic and biotechnology companies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.